FOXP3 and neoplasm: Beavis et al. also reported a role for anti-PD-1/CTLA-4 activated CD4+ Foxp3− cells in enhancing IL-12 production by CD103+ DCs, which in turn promoted T cell-mediated anti-tumor immunity in mice (42).